Yangyang Cai Xu Wang Ye Guo Chao Sun Yinghui Xu Shi Qiu Kewei Ma
10.1097/MD.0000000000013890
Medicine (Baltimore)
2019 Jan;98(1):e13890.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30608413/
Adenocarcinoma of Lung / drug therapy Afatinib / therapeutic use Antineoplastic Agents / therapeutic use Lung Neoplasms / drug therapy
Adenocarcinoma of Lung / drug therapy Afatinib / therapeutic use Antineoplastic Agents / therapeutic use Lung Neoplasms / drug therapy Case Reports Adenocarcinoma of Lung / genetics ErbB Receptors / genetics Exons Female Humans Lung Neoplasms / genetics Middle Aged Mutagenesis, Insertional Antineoplastic Agents Afatinib EGFR protein, human ErbB Receptors
PMC6344163
30608413
Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib: A case report
2019